BACE1 levels have been shown to increase in cells exposed to oxidative stress [45–48], apoptosis [8], in in vivo animal models following TBI [10, 49, 50], cerebral ischemia [8, 51] and impaired energy metabolism [52]. This evidence concerns the gene BACE1 and brain ischemia.